当前位置:首页 - 行情中心 - 康拓医疗(688314) - 财务分析 - 现金流量表

康拓医疗

(688314)

  

流通市值:25.11亿  总市值:25.11亿
流通股本:8162.83万   总股本:8162.83万

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金197,174,507.2988,588,307.38380,775,213.92277,982,714.47
  收到其他与经营活动有关的现金7,774,739.96856,840.59,752,987.229,117,050.36
  经营活动现金流入小计204,949,247.2589,445,147.88390,528,201.14287,099,764.83
  购买商品、接受劳务支付的现金37,842,225.0821,174,462.5371,186,105.8446,688,064.22
  支付给职工以及为职工支付的现金46,348,361.5920,311,350.4979,278,177.5661,351,111.76
  支付的各项税费24,288,072.7611,898,419.5749,799,108.1839,683,723.15
  支付其他与经营活动有关的现金36,862,170.8414,934,221.7872,223,345.8353,293,320.13
  经营活动现金流出小计145,340,830.2768,318,454.37272,486,737.41201,016,219.26
  经营活动产生的现金流量净额59,608,416.9821,126,693.51118,041,463.7386,083,545.57
二、投资活动产生的现金流量:
  收回投资收到的现金255,000000
  取得投资收益收到的现金1,275,800.97265,195.042,213,670.051,161,679.21
  处置固定资产、无形资产和其他长期资产收回的现金净额5,0005,0003,513.52,800
  收到的其他与投资活动有关的现金349,000,000148,000,000813,000,000628,000,000
  投资活动现金流入小计350,535,800.97148,270,195.04815,217,183.55629,164,479.21
  购建固定资产、无形资产和其他长期资产支付的现金22,738,394.1317,374,950.3851,389,118.4336,463,636.22
  投资支付的现金25,400,248.916,900,00015,000,00027,747,374
  取得子公司及其他营业单位支付的现金0046,844,363.580
  支付其他与投资活动有关的现金429,206,508319,208,101818,351,250758,000,000
  投资活动现金流出小计477,345,151.03353,483,051.38931,584,732.01822,211,010.22
  投资活动产生的现金流量净额-126,809,350.06-205,212,856.34-116,367,548.46-193,046,531.01
三、筹资活动产生的现金流量:
  吸收投资收到的现金5,439,618000
  取得借款收到的现金10,000,000030,000,0000
  筹资活动现金流入小计15,439,618030,000,0000
  偿还债务支付的现金550,000300,00000
  分配股利、利润或偿付利息支付的现金27,286,923.58628,668.4232,779,164.0132,252,025.09
  支付其他与筹资活动有关的现金1,257,781.27313,712.363,191,348.551,325,669.04
  筹资活动现金流出小计29,094,704.851,242,380.7835,970,512.5633,577,694.13
  筹资活动产生的现金流量净额-13,655,086.85-1,242,380.78-5,970,512.56-33,577,694.13
四、汇率变动对现金及现金等价物的影响-558,348.45-295,421.06-165,402.59-28,578.29
五、现金及现金等价物净增加额-81,414,368.38-185,623,964.67-4,461,999.88-140,569,257.86
  加:期初现金及现金等价物余额373,281,344.49373,281,344.49377,743,344.37377,743,344.37
  期末现金及现金等价物余额291,866,976.11187,657,379.82373,281,344.49237,174,086.51
补充资料:
  净利润40,403,700.69-97,748,316.83-
  资产减值准备1,503,894.09-4,156,542.61-
  固定资产和投资性房地产折旧5,057,387.25-7,968,677.44-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧5,057,387.25-7,968,677.44-
  无形资产摊销6,581,702.9-5,205,177.5-
  长期待摊费用摊销423,348.03-1,876,301.87-
  处置固定资产、无形资产和其他长期资产的损失0--713.5-
  固定资产报废损失32,071.55-378,802.98-
  公允价值变动损失-279,167.5-285,272.93-
  财务费用1,487,661.17-2,321,892.79-
  投资损失25,536.01-8,923,062.6-
  递延所得税-2,823,268.52--1,916,153.79-
  其中:递延所得税资产减少-1,527,105.12--413,860.66-
    递延所得税负债增加-1,296,163.4--1,502,293.13-
  存货的减少-7,639,960.68--9,862,827.77-
  经营性应收项目的减少7,501,424.13--15,556,907.4-
  经营性应付项目的增加-1,482,292.71-5,975,310.79-
  其他6,387,706.19-6,987,457.89-
  债务转为资本0-0-
  一年内到期的可转换公司债券0-0-
  融资租入固定资产0-0-
  现金的期末余额291,866,976.11-373,281,344.49-
  减:现金的期初余额373,281,344.49-377,743,344.37-
  加:现金等价物的期末余额0-0-
  减:现金等价物的期初余额0-0-
  现金及现金等价物的净增加额-81,414,368.38--4,461,999.88-
公告日期2026-08-282026-04-292026-03-312025-10-28
审计意见(境内)标准无保留意见
TOP↑